Click here to sign up for our free daily newsletter.

Health Canada authorizes updated Novavax COVID-19 vaccine targeting XBB variant

Dec 5, 2023 | 2:45 PM

OTTAWA — Health Canada has authorized an updated COVID-19 vaccine from Novavax that targets the XBB.1.5 variant. 

The new vaccine is called Nuvaxovid and is approved for people 12 years of age and over. 

Nuvaxovid is a protein subunit vaccine, meaning it contains harmless pieces of virus. 

The other two XBB vaccines currently authorized in Canada are mRNA vaccines, manufactured by Pfizer-BioNTech and Moderna.